Supporting the Rare Disease Community in India

Patient Registry

It is estimated that 70 Million rare disease patients live in India. However, there is scant epidemiological data about the extent and number of cases. This lack of information has led to difficulties in research and development, making correct and timely diagnosis and understanding the pathogenicity of variants specific to the Indian population. About 80% of rare diseases have a genetic origin.

Innovations in genetics and molecular technologies have led to a rapid decline in costs and diagnosis of these disorders has become routine in Indian hospitals and clinics. However, there is no infrastructure for easily and securely sharing information between the different academic institutes and healthcare providers in India.

The need of the hour is a systematic collection of clinical, genetic and biologic information in the form of longitudinal patient registries and data sources.

Qlinics is creating a cloud-based platform that can be used by geneticists, clinician and even patient groups to securely create, store and access patient registry data. The platform will be free-to-use and it is hoped that it can fill the enormous gaps in the critical cooperation infrastructure needed to further the management of rare diseases.

Clinical trials for rare diseases


cloud computing

Cloud computing and its allied disciplines like Artificial Intelligence (AI) / Machine Learning (ML) are revolutionising the way healthcare data is collected, managed and used.

Qlinics is dedicated to providing a secure, compliant, high quality, easy-to-use cloud platform that will enable researchers and clinicians share and collaborate and generate insights that were not visible before.

Ecommerce for genetics laboratories

Genetic tests for rare diseases are an example of a 'long tail' distribution with a large number of tests available for the approximately 7000 disorders with a very low volume of each test. The ordering clinicians and patients are distributed all over the country. This model lends itself very well to an e-commerce presence. This offers an extensive reach at very low costs.

Please see an example of an e-commerce site for genetic disorders at Labnetworx